Abstract:Accumulating evidence supports the role of microbiota in autoimmune processes, but research regarding the role of the gut microbiota in celiac disease (CD) is still emerging, and a consistent CD-associated dysbiosis pattern has not yet been defined. Here, we characterized the microbiota of children newly diagnosed with CD, with their unaffected family members as a healthy control group to reduce confounding factors including genetic background, hygiene, dietary habits, and environment, and followed children with CD over 1 year of dietary intervention (exclusion of gluten) to understand if the microbiota is associated with CD and its mediation. We did not find differences in the microbiota of siblings with and without CD, despite a wealth of evidence in the literature supporting CD-specific microbiota. CD is common among first-degree relatives, so this could suggest that unaffected family members in this study may be living in a pre-CD state, currently below clinical detection. Interestingly, despite the effectiveness of diet in CD control, we did not observe diet-mediated microbiota changes, except for short-term increase in Akkermansia muciniphila. This lack of effect could suggest a very strong CD microbial signature even when controlled or could be a technical shortcoming. Expanded future studies with both related and unrelated controls and diet interventions in both the CD and control arms can provide further context to our findings. IMPORTANCE The microbiota is the community of microbes that live in and on us. These microbes are essential to our health and everyday function. Disruption of the community is associated with diseases ranging from metabolic syndrome to autoimmune diseases to mental disorders. In the case of celiac disease (CD), research remains inconclusive regarding implications of the microbiota in etiology. Here, we compared microbiota of children with CD to those of their unaffected family members and found very few differences in microbiota profiles. We next examined how gluten elimination in CD patients affects the microbiota. Surprisingly, despite diet adherence, microbiota shifts were minimal, with only a short-term increase in Akkermansia muciniphila. Previous studies suggest that family members of CD patients may be living in a pre-CD state, which could explain their microbial similarity. A larger study with unrelated controls and increased microbiota monitoring during diet intervention should give our findings more perspective.

Use of Serological Markers as a Screening Test in Family Members of Patients with Celiac Disease

Detection of asymptomatic celiac disease in two siblings from a mother with non-celiac gluten sensitivity

The role of serology in the diagnosis of coeliac disease

Efficacy Study of Anti-Endomysium Antibodies for Celiac Disease Diagnosis: A Retrospective Study in a Spanish Pediatric Population

Characteristics of Siblings With Celiac Disease Diagnosed by Family Screening

Accuracy of Serological Screening for the Diagnosis of Celiac Disease in Type 1 Diabetes Children

Biomarkers for diagnosis and monitoring of celiac disease

Antibodies to Gliadin by ELISA as a Screening Test for Childhood Celiac Disease

Non-Invasive Markers of Inflammation and Protein Loss Augment Diagnosis of Pediatric Celiac Disease

Coeliac Disease Case-Control Study: Has the Time Come to Explore beyond Patients at Risk?

Diagnosis of celiac disease on a gluten-free diet: a multicenter prospective quasi-experimental clinical study

Clinical significance of detecting anti-Saccharomyces cerevisiae antibody in Crohn′s disease

Clinical Significance Of Anti-Sacchromyces Cerevisiae Antibody In Crohn'S Disease: A Single-Center Study

Study on Joint Detection of Serological Markers in the Diagnosis of Crohn's Disease

Celiac Disease Screening for High-Risk Groups: Are We Doing It Right?

Celiac disease diagnosis: transglutaminase, duodenal biopsy and genetic tests correlations

Adherence to dietary treatment and clinical factors associated with anti-transglutaminase antibodies in celiac disease during the follow-up

Endomysial Antibodies as Unreliable Markers for Slight Dietary Transgressions in Adolescents with Celiac Disease

Celiac-the lone horse? An autoimmune condition without signals of microbiota dysbiosis

Celiac disease-related conditions: Who to test?

Feasibility of a "No-Biopsy" Approach for the Diagnosis of Celiac Disease in Symptomatic Adults